-
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Source: Buzz FX / 15 Mar 2025 09:52:17 America/New_York
Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Shares of Allogene Therapeutics, Inc.
Read more...